Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Lerner

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Leukemia & Lymphoma|July 31, 2012
Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsinYoun H Kim, Marie-France Demierre, Ellen J Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphomaSean J Whittaker, Marie-France Demierre, Ellen J Kim, et al.
Cellular Signalling|September 5, 2017
Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assaysAna Santos de Medeiros, Arlene R Wyman, Manal A Alaamery, et al.
Critical Care (London, England)|April 6, 2016
Thiamine as an adjunctive therapy in cardiac surgery: a randomized, double-blind, placebo-controlled, phase II trialLars W Andersen, Mathias J Holmberg, Katherine M Berg, et al.
British Journal of Haematology|November 19, 2014
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphomaFrancine Foss, Ranjana Advani, Madeleine Duvic, et al.
AJOB Empirical Bioethics|February 26, 2020
Experimental Philosophical BioethicsBrian D Earp, Joanna Demaree-Cotton, Michael Dunn, et al.
Nature Medicine|August 22, 2018
De novo NAD<sup>+</sup> biosynthetic impairment in acute kidney injury in humansAli Poyan Mehr, Mei T Tran, Kenneth M Ralto, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Leukemia & Lymphoma|July 31, 2012
Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsinYoun H Kim, Marie-France Demierre, Ellen J Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphomaSean J Whittaker, Marie-France Demierre, Ellen J Kim, et al.
Cellular Signalling|September 5, 2017
Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assaysAna Santos de Medeiros, Arlene R Wyman, Manal A Alaamery, et al.
Critical Care (London, England)|April 6, 2016
Thiamine as an adjunctive therapy in cardiac surgery: a randomized, double-blind, placebo-controlled, phase II trialLars W Andersen, Mathias J Holmberg, Katherine M Berg, et al.
British Journal of Haematology|November 19, 2014
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphomaFrancine Foss, Ranjana Advani, Madeleine Duvic, et al.
AJOB Empirical Bioethics|February 26, 2020
Experimental Philosophical BioethicsBrian D Earp, Joanna Demaree-Cotton, Michael Dunn, et al.
Nature Medicine|August 22, 2018
De novo NAD<sup>+</sup> biosynthetic impairment in acute kidney injury in humansAli Poyan Mehr, Mei T Tran, Kenneth M Ralto, et al.
Pageof 7